Skip to main content
Log in

Effects of Proton Pump Inhibitors in Patients Receiving Clopidogrel

Meta-Analysis versus Clinical Practice

  • Correspondence
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Kwok CS, Nijjar RS, Loke YK. Effects of proton pump inhibitors on adverse gastrointestinal events in patients receiving clopidogrel: systematic review and meta-analysis. Drug Saf 2011; 34(1): 47–57

    Article  PubMed  CAS  Google Scholar 

  2. Kwok CS, Loke YK. Meta-analysis: the effects of proton pump inhibitors on cardiovascular events and mortality in patients receiving clopidogrel. Aliment Pharmacol Ther 2010; 31: 810–23

    PubMed  CAS  Google Scholar 

  3. Van Boxel OS, van Oijen MG, Hagenaars MP, et al. Cardiovascular and gastrointestinal outcomes in clopidogrel users on proton pump inhibitors: results of a large Dutch cohort study. Am J Gastroenterol 2010; 105: 2430–6

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

M.G.H. van Oijen has received unrestricted research grants from AstraZeneca and Janssen, and serves as a consultant for AstraZeneca and Pfizer. P.D. Siersema has received unrestricted research grants from AstraZeneca, Janssen and Nycomed, and serves as a consultant for AstraZeneca, Janssen, Movetis and Pfizer.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

van Oijen, M.G.H., Siersema, P.D. Effects of Proton Pump Inhibitors in Patients Receiving Clopidogrel. Drug-Safety 34, 173 (2011). https://doi.org/10.2165/11588430-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11588430-000000000-00000

Keywords

Navigation